DealForma (@dealforma) 's Twitter Profile
DealForma

@dealforma

The deal and funding database built for biopharma. Curated deal comps, company profiles, pipelines, dedicated analyst support so you do better research faster

ID: 826231652930031616

linkhttp://dealforma.com calendar_today31-01-2017 00:52:31

279 Tweet

363 Followers

256 Following

DealForma (@dealforma) 's Twitter Profile Photo
DealForma
@dealforma

2 months ago

In 2023-2024 YTD, the top M&A buyers by upfront cash and equity include Pfizer Inc. at $43.4 billion, BMS at $22.9 billion, @AbbVie at $18.9 billion, and J&J/Janssen at $17.6 billion. Want to see more charts like this? Schedule your demo hubs.ly/Q02JjqLd0

In 2023-2024 YTD, the top M&amp;A buyers by upfront cash and equity include <a href="/pfizer/">Pfizer Inc.</a> at $43.4 billion, BMS at $22.9 billion, @AbbVie at $18.9 billion, and J&amp;J/Janssen at $17.6 billion. Want to see more charts like this? Schedule your demo hubs.ly/Q02JjqLd0